|
Facebook
Twitter
Linkedin
|
 |
 |
 |
 |
SenoRx
SenoRx (NASDAQ: SENO) develops, manufactures and sells minimally invasive medical devices for the diagnosis and treatment of breast cancer
About SenoRx
SenoRx specializes in the development of instruments utilized in the diagnosis and treatment of breast cancer - Including the advanced technology EnCor vacuum assisted breast biopsy system and the Contura Multi-Lumen Balloon for APBI providing optimal dosimetric coverage for any brachytherapy case, minimizing radiation dose to healthy tissues.
SenoRx Details
Company Name
SenoRxAddress
3 Morgan, Irvine, CA 92618Headquarters City
Irvine, CaliforniaCompany Type
PublicStock Exchange & Symbol
NASDAQ: SENOFounded
1998Country of Incorporation
USACEO & Chairman Of Board
Lloyd MalchowPresident
John BuhlerProduct Areas
SenoRx News
- SenoRx Completes Sale to C. R. Bard
- SenoRx to be Acquired by C. R. Bard
- SenoRx Reports Continuing Revenue Growth in Q1 '10
- SenoRx' First Quarter 2010 Conference Call & Webcast
- SenoRx Board Appoints John T. Buhler as CEO
- SenoRx Mourns Death of CEO
- SenoRx: Fourth Quarter, Fiscal Year 2009 Results
- SenoRx Announces Q4/FY2009 Conference Call
- RFID By SenoRx For Breast Cancer
- SenoRx Conducts Market Research on RFID at RSNA 2009
2553
